Women's Bodies, Women's Wisdom (199 page)

103
. G. A. Greendale et al., “Effects of the Menopause Transition and Hormone Use on Cognitive Performance in Midlife Women,”
Neurology,
vol. 72, no. 21 (May 26, 2009), pp. 1850–7.

104
. K. J. Chang et al., “Influences of Percutaneous Administration of Estradiol and Progesterone on Human Breast Epithelial Cell Cycle in Vivo,”
Fertility and Sterility,
vol. 63, no. 4 (April 1995), pp. 785–91; M. J. Foidart et al., “Estradiol and Progesterone Regulate the Proliferation of Human Breast Epithelial Cells,”
Fertility
and Sterility,
vol. 69, no. 5 (May 1998), pp. 963–69.

105
. J. C. Prior, “Perimenopause: The Complex Endocrinology of the Menopausal Transition,”
Endocrine Reviews,
vol. 19, no. 4 (Aug. 1998), pp. 397–428.

106
. S. Franceschi, A. Gavero, A. Decarli, et al., “Intake of Macronutrients and Risk of Breast Cancer,”
The Lancet,
vol. 347 (1996), pp. 1351–6; A. Tavam et al., “Consumption of Sweet Foods and Breast Cancer Risk in Italy,”
Annals of Oncology
(Oct. 2005) [Epub ahead of print].

107
. E. Ginsburg, N. Mello, et al., “Effects of Alcohol Ingestion on Estrogens in Postmenopausal Women,”
Journal of the American Medical Association,
vol. 276, no. 21 (1996), pp. 1747–51.

108
. M. Eades and M. D. Eades,
Protein Power
(New York: Bantam Books, 1996). Both the Eadeses and the Hellers have done groundbreaking research on the effects of diet, excessive fat, and insulin on health. Both teams are available for consultation with physicians, and their books are excellent practical guides for patients and physicians alike.

109
. J. Jeppesen et al., “Effects of Low-Fat, High-Carbohydrate Diets on Risk Factors for Ischemic Heart Disease in Postmenopausal Women,”
American Journal of
Clinical Nutrition,
vol. 65 (1997), pp. 1027–33.

110
. M. Kearney et al., “William Heberden Revisited: Postprandial Angina Interval— Interval Between Food and Exercise and Meal Consumption Are Important Determinants of Time of Onset of Ischemia and Maximal Exercise Tolerance,”
Journal
of the American College of Cardiology,
vol. 29 (1997), pp. 302–7.

111
. B. M. Altura et al., “Cardiovascular Risk Factors and Magnesium: Relationships to Atherosclerosis, Ischemic Heart Disease, and Hypertension,”
Magnesium and
Trace Elements,
vol. 10 (1991–92), pp. 182–92; R. DeGronzo and E. Ferrannini, “Insulin Resistance: A Multifaceted Syndrome Responsible for NIDDM, Obesity, Hypertension, Dyslipidemia, and Atherosclerotic Cardiovascular Disease,”
Diabetes
Care,
vol. 14, no. 3 (1991), pp. 173–94; A. Ferrara et al., “Sex Differences in Insulin Levels in Older Adults and the Effect of Body Size, Estrogen Replacement Therapy, and Glucose Tolerance Status: The Rancho Bernardo Study, 1984–87,”
Diabetes Care,
vol. 18, no. 2 (1995), pp. 220–25; J. M. Gaziano, “Antioxidant Vitamins and Coronary Artery Disease Risk,”
American Journal of Medicine,
vol. 97 (1994), pp. 3A–18S, 21S; J. Hallfrisch et al., “High Plasma Vitamin C Associated with High Plasma HDL and HDL(2) Cholesterol,”
American Journal of Clinical
Nutrition,
vol. 60 (1994), pp. 100–5; M. Modan et al., “Hyperinsulinemia: A Link Between Hypertension, Obesity, and Glucose Intolerance,”
Journal of Clinical Investigation,
vol. 75 (1985), pp. 809–17; H. Morrison et al., “Serum Folate and Risk of Fatal Coronary Heart Disease,”
Journal of the American Medical Association,
vol. 275, no. 24 (June 26, 1996), pp. 1893–6; R. A. Riemersma et al., “Risk of Angina Pectoris and Plasma Concentrations of Vitamins A, E, C, and Carotene,”
The Lancet,
vol. 337 (1991), pp. 1–5; M. Stampfer et al., “Vitamin E Consumption and the Risk of Coronary Heart Disease in Women,”
New England Journal of
Medicine,
vol. 328, no. 20 (May 20, 1993), pp. 1444–9; D. Steinberg et al., “Antioxidants in the Prevention of Human Atherosclerosis,”
Circulation,
vol. 85, no. 6 (1972), pp. 2338–43; D. A. Street et al., “A Population Based Case Control Study of the Association of Serum Antioxidants and Myocardial Infarction,”
American
Journal of Epidemiology,
vol. 124 (1991), pp. 719–20.

112
. M. Studer et al., “Effect of Different Antilipidemic Agents and Diets on Mortality: A Systematic Review,”
Archives of Internal Medicine,
vol. 165, no. 7 (Apr. 11, 2005), pp. 725–30.

113
. M. Daviglus et al., “Fish Consumption and the 30-Year Risk of Fatal Myocardial Infarction,”
New England Journal of Medicine,
vol. 336, no. 15 (April 10, 1997), pp. 1046–53.

114
. R. K. Hermsmeyer et al., “Cardiovascular Effects of Medroxyprogsterone Acetate and Progesterone: A Case of Mistaken Identity?”
Nature Clinical Practice. Cardiovascular
Medicine,
vol. 5, no. 7 (July 2008), pp. 387–95.

115
. Alzheimer’s Association, “2009 Alzheimer’s Disease Facts and Figures,”
Alzheimer’s and Dementia,
vol. 5, no. 3 (May 2009), pp. 234–70.

116
. S. D. Edland et al., “Dementia and Alzheimer Disease Incidence Rates Do Not Vary by Sex in Rochester, Minn.,”
Archives of Neurology,
vol. 59, no. 10 (Oct. 2002), pp. 1589–93.

117
. D. Snowden et al., “Linguistic Ability in Early Life and Cognitive Function and Alzheimer’s Disease in Late Life,”
Journal of the American Medical Association,
vol. 275, no. 7 (February 21, 1996), pp. 528–32.

118
. M. A. Espeland et al., “Conjugated Equine Estrogens and Global Cognitive Function in Postmenopausal Women: Women’s Health Initiative Memory Study,”
Journal
of the American Medical Association,
vol. 291, no. 24 (June 23, 2004), pp. 2959–68.

119
. T. L. Loucks and S. L. Berga, “Does Postmenopausal Estrogen Use Confer Neuroprotection?”
Seminars in Reproductive Medicine,
vol. 27, no. 3 (May 2009), pp. 260–74.

120
. V. Henderson et al., “Estrogen Replacement Therapy in Older Women: Comparisons Between Alzheimer’s Disease Cases and Nondemented Control Subjects,”
Archives of Neurology,
vol. 51 (1994), pp. 896–900; H. Honjo, Y. Ogina, K. Tanaka, et al., “An Effect of Conjugated Estrogen to Cognitive Impairment in Women with Senile Dementia, Alzheimer’s Type: A Placebo-Controlled Double Blind Study,”
Journal of the Japanese Menopause Society,
vol. 1 (1993), pp. 167–71; T. Ohkura, K. Isse, K. Akazawa, et al., “Evaluation of Estrogen Treatment in Female Patients with Dementia of the Alzheimer’s Type,”
Endocrine Journal,
vol. 41 (1994), pp. 361–71; A. Paganini-Hill and V. W. Henderson, “Estrogen Deficiency and Risk of Alzheimer’s Disease in Women,”
American Journal of Epi-demiology,
vol. 140 (1994), pp. 256–61.

121
. J. F. Flood, J. E. Morley, and E. Roberts, “Memory-Enhancing Effects in Male Mice of Pregnenolone and Steroids Metabolically Derived from It,”
Proceedings
from the National Academy of Sciences,
vol. 89 (Mar. 1992), pp. 1567–71: C. R. Mevril et al., “Reduced Plasma DHEA Concentrations in HIV Infection and Alzheimer’s Disease,” in M. Kalimi and W. Regelson, eds.,
The Biological Role of
Dehydroepiandrosterone
(New York: de Gruyter, 1990), pp. 101–5; W. Regelson et al., “Dehydroepiandrosterone (DHEA)—The ‘Mother Steroid.’ I. Immunologic Action,”
Annals of the New York Academy of Sciences,
vol. 719 (1994), pp. 553–63; S. S. C. Yen et al., “Replacement of DHEA in Aging Men and Women: Potential Remedial Effects,”
Annals of the New York Academy of Sciences,
vol. 774 (1995), pp. 128–42.

122
. M. Freedman, J. Knoefel, et al., “Computerized Axial Tomography in Aging,” in M. L. Albert, ed.,
Clinical Neurology of Aging
(New York: Oxford University Press, 1984); U. Lehr and R. Schmitz-Scherzer, “Survivors and Non-Survivors: Two Fundamental Patterns of Aging,” in H. Thomas, ed.,
Patterns of Aging
(Basel: S. Karger, 1976); A. L. Benton, P. J. Eslinger, and A. R. Damasio, “Normative Observations on Neuropsychological Test Performance in Old Age,”
Journal
of Clinical Neuropsychiatry,
vol. 3 (1981), pp. 33–42.

123
. P. H. Evans, J. Klinowski, and E. Yano, “Cephaloconiosis: A Free Radical Perspective on the Proposed Particulate-Induced Etiopathogenesis of Alzheimer’s Dementia and Related Disorders,”
Medical Hypotheses,
vol. 34 (1991), pp. 209–19; I. Rosenberg and J. Miller, “Nutritional Factors in Physical and Cognitive Functions of Elderly People,”
American Journal of Clinical Nutrition,
vol. 55 (1992), pp. 1237S–1243S; R. N. Strachan and J. G. Henderson, “Dementia and Folate Deficiency,”
Quarterly Journal of Medicine,
vol. 36 (1967), pp. 189–204.

124
. Weed, from an introductory flyer for
Menopausal Years
.

Chapter 15

1
. Exercise adapted from a workshop author participated in with Annie O’Toole.

2
. This teaching is from Abraham, who teaches through Esther Hicks. I’ve consistently found the Abraham teachings to be very practical material for living joyfully. For more information, visit
www.abraham-hicks.com
.

3
. Bruce Lipton, Ph.D., made this comment on the program
Flourish! with Dr. Chris-tiane
Northrup,
Hay House radio, October 21, 2009.

4
. Leslie Kussman, personal communication (May 6, 1992), before filming
Harbour
of Hope,
a documentary about those who have healed from chronic or terminal illness. For information write Aquarius Production, 31 Martin Road, Wellesley, MA 02181; 617-237-0608.

5
. Vicki Robin and Joe Dominguez,
Your Money or Your Life: 9 Steps to Transforming
Your Relationship with Money and Creating Financial Independence
(New York: Penguin, 2008).

6
. At one of my workshops a woman from Atlanta told me that her woman’s group simply calls this deep work “the process.” She had never heard of Anne Wilson Schaef or her work.

7
. Naomi Wolf has documented the tragic aspects of this in
The Beauty Myth
(New York: Morrow, 1990).

8
. Florence Scovel Shinn,
The Game of Life and How to Play It
(Marina del Rey, CA: DeVorss and Co., 1925).

9
. Patricia Reis, author of
Through the Goddess
(Freedom, CA: Crossing Press, 1991), worked with us at Women to Women for four years, teaching us the deep patterns held in women’s psyches and bodies.

10
. An in-depth approach to this is available in Vicki Noble,
Shakti Woman
(Harper-SanFrancisco, 1992).

11
. For more information, write to the Proprioceptive Writing Center, 1001 53rd St., Oakland, CA 94608; 510-350-8799.

12
. Dream incubation is adapted from the work of Patricia Reis.

13
. D. Spiegel, J. Bloom, H. D. Kraemer, et al., “Effects of Psychosocial Treatment on Survival of Patients with Metastatic Breast Cancer,”
The Lancet,
vol. 2 (1989), pp. 888–91; D. Spiegel, “A Psychosocial Intervention and Survival Time of Patients with Metastatic Breast Cancer,”
Advances,
vol. 7, no. 3 (1991), pp. 10–19.

14
. Boston Women’s Health Book Collective,
The New Our Bodies, Ourselves
(New York: Simon & Schuster, Inc., 1984); Riane Eisler,
The Chalice and the Blade: Our
History, Our Future
(HarperSanFrancisco, 1988).

15
. N. Singer, “Medical Papers by Ghostwriters Pushed Therapy,”
New York Times
(August 5, 2009), p. A1.

16
. J. Law,
Big Pharma: Exposing the Global Healthcare Agenda
(New York: Carroll & Graf, 2006), p. 48; B. Lipton and S. Bhaerman,
Spontaneous Evolution: Our
Positive Future (And a Way to Get There from Here)
(Carlsbad, CA: Hay House, 2009), p. 208.

17
. C. Elliott, “The Drug Pushers,”
The Atlantic
(April 2006), also available online at
www.theatlantic.com/doc/200604/drug-reps
.

18
. F. Luskin and B. Bland, “Stanford–Northern Ireland Hope 2 Project,” unpublished manuscript, Stanford University, Palo Alto, CA (Feb. 2001).

19
. R. McCraty et al., “The Effects of Emotions on Short-Term Power Spectrum Analysis of Heart Rate Variability,”
American Journal of Cardiology,
vol. 76, no. 14 (Nov. 15, 1995), pp. 1089–93; Doc Lew Childre,
Women Lead with Their
Hearts: A White Paper,
obtainable from the Institute of HeartMath, P.O. Box 1463, Boulder Creek, CA 95006; 831-338-8500; website:
www.hearthealth.org
.

20
. Stephen Levine,
Guided Meditations, Explorations and Healings
(New York: Doubleday, 1991), p. 324.